Effect of the tumor promoter phenobarbital on the pattern of global gene expression in liver of connexin32-wild-type and connexin32-deficient mice

International Journal of Cancer

Volumn 115, Issue 6, 2005, Pages 861-869

  Stahl, Sabine ^a   Ittrich, Carina ^b   Marx Stoelting, Philip ^a   Köhle, Christoph ^a   Ott, Thomas ^c   Buchmann, Albrecht ^a   Schwarz, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Connexin32; Gene expression profiling; Hepatocarcinogenesis; Phenobarbital

Indexed keywords

ANTICONVULSIVE AGENT; COMPLEMENTARY DNA; CONNEXIN 32; PHENOBARBITAL; RETINOL DEHYDROGENASE; RETINOL DEHYDROGENASE 6; RNA; SOMATOMEDIN BINDING PROTEIN 1; TUMOR PROMOTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DBY GENE; DNA HYBRIDIZATION; DRUG CARCINOGENICITY; GENE; GENE EXPRESSION; GENE INDUCTION; GENE REPRESSION; LIVER CANCER; LIVER CARCINOGENESIS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; STATISTICAL ANALYSIS; TRANSCRIPTION INITIATION; TUMOR PROMOTION; UNINDEXED SEQUENCE; WESTERN BLOTTING; WILD TYPE; Y CHROMOSOME;

ANIMALS; CARCINOGENS; CONNEXINS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; LIVER; MALE; MICE; MICE, MUTANT STRAINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOBARBITAL;

EID: 20344376405     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20815     Document Type: Article

References (40)

1. Yamasaki H, Naus CC. Role of connexin genes in growth control. Carcinogenesis 1996;17:1199-213.
2. Trosko JE, Ruch RJ. Cell-cell communication in carcinogenesis. Front Biosci 1998;3:D208-36.
3. Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996;84:381-88.
4. Janssen-Timmen U, Traub O, Dermietzel R, Rabes HM, Willecke K. Reduced number of gap junctions in rat hepatocarcinomas detected by monoclonal antibody. Carcinogenesis 1986;7:1475-82.
5. Temme A, Buchmann A, Gabriel HD, Neues E, Schwarz M, Willecke K. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr Biol 1997;7:713-6.
6. Moennikes O, Buchmann A, Ott T, Willecke K, Schwarz M. The effect of connexin32 null mutation on hepatocarcinogenesis in different mouse strains. Carcinogenesis 1999;20:1379-82.
7. Moennikes O, Buchmann A, Romualdi A, Ott T, Werringloer J, Willecke K, Schwarz M. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice. Cancer Res 2000; 60:5087-91.
8. Wei P, Zhang J, Egan-Hafley M, Liang S, Moore DD. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 2000;407:920-3.
9. Honkakoski P, Negishi M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J 2000;347:321-37.
10. Waxman DJ. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys 1999;369:11-23.
11. Ueda A, Hamadeh HK, Webb HK, Yamamoto Y, Sueyoshi T, Afshari CA, Lehmann, JM, Negishi M. Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol Pharmacol 2002;61:1-6.
12. Nelles E, Buetzler C, Jung D, Temme A, Gabriel HD, Dahl U, Traub O, Stuempel F, Jungermann K, Zielasek J, Toyka KV, Demietzel R, et al. Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc Natl Acad Sci USA 1996;93:9565-70.
13. Wu Z, Irizarry RA. Stochastic models inspired by hybridization theory for short oligonucleotide arrays. Proc RECOMB 2004.
14. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003;31:e15.
15. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185-93.
16. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003.
17. R-Development-Core-Team. R: a language and environment for statistical computing. Vienna, Austria, 2003.
18. Harell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer, 2001.
19. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
20. Aydinlik H, Nguyen TD, Moennikes O, Buchmann A, Schwarz M. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. Oncogene 2001;20:7812-6.
21. Wolfinger RD, Gibson G, Wolfinger ED, Bennett L, Hamadeh H, Bushel P, Afshari C, Paules RS. Assessing gene significance from cDNA microarray expression data via mixed models. J Comput Biol 2001;8:625-37.
22. Pitot HC, Dragan YP. The multistage nature of chemically induced hepatocarcinogenesis in the rat. Drug Metabolism Reviews 1994;26: 209-20.
23. Willecke K, Temme A, Teubner B, Ott T. Characterization of targeted connexin32-deficient mice: A model for the human Charcot-Marie-Tooth (X-type) inherited disease. Ann NY Acad Sci 1999;883:302-09.
24. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Guldenagel M, Deutsch U, Sohl G. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002;383:725-37.
25. Temme A, Ott T, Dombrowski F, Willecke K. The extent of synchronous initiation and termination of DNA synthesis in regenerating mouse liver is dependent on connexin32 expressing gap junctions. J Hepatol 2000;32:627-35.
26. Frueh FW, Zanger UM, Meyer LJA. Extent and character of phenobarbital-mediated changes in gene expression in the liver. Mol Pharmacol 1997;51:363-9.
27. Shibutani M, Takahashi N, Kobayashi T, Uneyama C, Masutomi N, Nishikawa A, Hirose M. Molecular profiling of genes up-regulated during promotion by phenobarbital treatment in a medium-term rat liver bioassay. Carcinogenesis 2002;23:1047-55.
28. Garcia-Allan C, Lord PG, Loughlin JM, Orton TC, Sidaway JE. Identification of phenobarbitone-modulated genes in mouse liver by differential display. J Biochem Mol Toxicol 2000;14:65-72.
29. Leu JI, Crissey MA, Taub R. Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. J Clin Invest 2003;111:129-39.
30. Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, Goseki N, Matsubara O, Takenaka K, Shichita M, Tanaka R, Shuda M, et al. Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res 1999;59:4990-6.
31. Schulte-Hermann R, Bursch W, Grasl-Kraupp B, Torok L, Ellinger AL, Mullauer L. Role of active cell death (apoptosis) in multi-stage carcinogenesis. Toxicol Lett 1995;82-83:143-8.
32. Buchmann A, Willy C, Buenemann CL, Stroh C, Schmiechen A, Schwarz M. Inhibition of transforming growth factor beta 1-induced hepatoma cell apoptosis by liver tumor promoters: characterization of primary signaling events and effects on CPP32-like caspase activity. Cell Death Differ 1999;6:190-200.
33. Bannasch P, Hacker HJ, Klimek F, Mayer D, Stumpf H, Zerban H. Cytochemical, microbiochemical and molecular genetic analysis of chemical carcinogenesis. Prog Histochem Cytochem 1991;23:45-60.
34. Evert M, Ott T, Temme A, Willecke K, Dombrowski F. Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-deficient mice. Carcinogenesis 2002;23:697-703.
35. You LR, Chen CM, Yeh TS, Tsai TY, Mai RT, Lin CH, Lee YH. Hepatitis C virus core protein interacts with cellular putative RNA helicase. J Virol 1999;73:2841-53.
36. Mazeyrat S, Saut N, Grigoriev V, Mahadevaiah SK, Ojarikre OA, Rattigan A, Bishop C, Eicher EM, Mitchell MJ, Burgoyne PS. A Y-encoded subunit of the translation initiation factor Eif2 is essential for mouse spermatogenesis. Nat Genet 2001;29:49-53.
37. Chai X, Zhai Y, Napoli JL. cDNA cloning and characterization of a cis-retinol/3alpha-hydroxysterol short-chain dehydrogenase. J Biol Chem 1997;272:33125-31.
38. Forman BM, Tzameli I, Choi HS, Chen J, Simha D, Seol W, Evans RM, Moore DD. Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature 1998;395:612-5.
39. Kemp CJ, Leary CN, Drinkwater NR. Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous. Proc Natl Acad Sci USA 1989;86:7505-9.
40. Yamamoto Y, Moore R, Goldsworth TL, Negishi M, Maronpot RR. The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res 2004;64:7197-200.